Hints and tips:
...Sales at Roche were lifted by US demand for Covid-19 tests, but the Swiss pharma group said it expected revenues from coronavirus treatments to decline, a sign that corporate America believes the pandemic...
...It will certainly require evidence of a V-shaped economic recovery to ignite demand for cyclical and value stocks....
...We note management teams are well acquainted from Roche and financial synergies from such a transaction would be potentially significant, even despite the lack of therapeutic synergy, assuming significant...
...Nevertheless few could have predicted the ingenuity of the works she is exhibiting at Roche Court....
...DD’s Indap v NYU’s Damodaran: Is stock compensation good or bad?...
...The government has vowed to tackle the price of cancer medicines, threatening revenues for multinationals such as Eli Lilly, Roche and Novartis....
...More than a century has passed since the case of Bebb v Law Society in 1913, when the UK’s Court of Appeal upheld the Law Society’s ban on women working as lawyers....
...Corporate earnings reports and updates out today include Nestle, Roche, Gam, Publicis, Pernod Richard, SAP, Schroders, Travis P, Unilever, Genel, Rentokil and LSE....
...Roche’s Ocrevus for multiple sclerosis tops the list with a projected $3.3bn....
...Lorcan Roche Kelly and Lars Christensen debate a recent post over at Lars’s blog. A fun and vigorous debate but some possibly NSFW language:...
...“We expect the unlocking of fiscal spending to manifest itself in a V-shaped recovery for Thailand in H2 2014,” said analysts at ANZ. Elsewhere, markets were showing minor gains....
...Prof Roche is a graduate of Essec Business School where he gained a diploma, but he also holds two PhDs, one in psychology which he gained at Paris V University, and one in philosophy that he earned at Grenoble...
...(Financial Times) Roche is to buy Santaris Pharma for up to $450m in the latest piece of dealmaking by the Swiss pharmaceuticals group....
...The grower v merchant playing field is more level than ever and the majority of négociant businesses are every bit as motivated by quality as the small growers....
...“The V-shaped recovery in corporate profits seems to be at an end,” warned Barry Knapp, chief US equity strategist at Barclays Capital....
...But unlike GlaxoSmithKline’s success last week, Roche came off second best....
...Extensive installations at Kettle’s Yard in Cambridge, Mima in Middlesbrough, the New Art Centre at Roche Court, the Arts and Crafts House at Blackwell and Ingleby Gallery, Edinburgh, reached their culmination...
...The means of achieving increased savings in a period of declining or stagnating income is why hopes for a V-shaped recovery in the economy will not be fulfilled....
...“However, unlike some, we don’t feel that equities need a V-shaped profile to make further gains....
...But there are three key flaws to panglossian hopes for a bull market and a V-shaped economic recovery. The first flaw can be simply put....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...But there are three key flaws to panglossian hopes for a bull market and a V-shaped economic recovery writes David Roche of Independent Strategy....
...Bury the hatchet SAP v Oracle is one of the great mud-slinging matches in business....
...v=rNWTf3Gsnpc Roche, Edward M. ”Crafting a Strategy for Virtual Worlds: Eight Questions to Ask.” The Conference Board New York....
...Time to make up SAP v Oracle is one of business’s great mud-slinging matches....
International Edition